Records containing: Leukemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-15Phase 1/2 Study: CD45RA Depleted Peripheral Stem Cell Addback to Prevent Viral and Fungal Infections Following Alternative Donor TCRab/CD19 Depleted Hematopoietic Stem Cell Transplant
-
CLINICAL_TRIALS study record update · 2026-04-14Phase 1 Study to Determine the Safety and Tolerability of Ziftomenib Combinations for the Treatment of KMT2A-rearranged or NPM1-mutant Relapsed/Refractory Acute Myeloid Leukemia
-
CLINICAL_TRIALS study record update · 2026-04-09An Open, Multi-center, Randomized Trial Comparing Haploidentical HSCTs From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-09A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine
-
CLINICAL_TRIALS study record update · 2026-04-06Cohort of Patients With Chronic Myelomonocytic Leukemia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-06Umbrella Long-Term Follow-Up Protocol
-
CLINICAL_TRIALS study record update · 2026-04-03A Phase I Study to Investigate the Safety, Tolerability, and Preliminary Efficacy of Anti-CD30 Bispecific Antibody-Armed Anti-CD3-Activated Autologous T-Cells (CD30 biAb-AATC) in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-01A Phase 1/2a, Open-Label, Dose Escalation, and Dose Expansion Study to Assess the Safety and Efficacy of GDX012 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
-
CLINICAL_TRIALS study record update · 2026-03-31Feasibility Of Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
-
CLINICAL_TRIALS study record update · 2026-03-31A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial Of Quizartinib Administered in Combination With Induction and Consolidation Chemotherapy and Administered as Maintenance Therapy in Adult Patients With Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia
-
CLINICAL_TRIALS study record update · 2026-03-27A Phase II Clinical Trial of CPI-613 in Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-grade B-cell Lymphoma With Rearrangements of MYC and BCL2 and/or BCL6
-
CLINICAL_TRIALS study record update · 2026-03-25A Phase I Trial of Revumenib in Combination With 7+3 (7 Days of Cytarabine and 3 Days of Daunorubicin) + Midostaurin Induction Chemotherapy for the Frontline Treatment of NPM1 and FLT3 Mutated AML
-
CLINICAL_TRIALS study record update · 2026-03-23Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study
-
CLINICAL_TRIALS study record update · 2026-03-23Immuno-inflammatory Manifestations With or Without Clonal Hematopoiesis: Ambispective Cohort Study
-
CLINICAL_TRIALS study record update · 2026-03-19A Multicenter Prospective Study on Structuralized Follow-up Model Construction and Late Effect Burden of Childhood Hematological Malignancy Survivors (HEM-SURVIVE)
-
CLINICAL_TRIALS study record update · 2026-03-18A Phase 1 Study of Cytokine-induced Memory-like (CIML) NK Cells With Venetoclax as Consolidation Therapy in AML
-
CLINICAL_TRIALS study record update · 2026-03-11A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway-Mutant Acute Lymphoblastic Leukemia
-
CLINICAL_TRIALS study record update · 2026-03-10Clinical Study on the Safety and Efficacy of BiTE-EV Therapy in Relapsed/Refractory Acute B-Cell Lymphoblastic Leukemia
-
CLINICAL_TRIALS study record update · 2026-03-09Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
-
CLINICAL_TRIALS study record update · 2026-03-05Combination of Nivolumab and Ipilimumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS)
-
CLINICAL_TRIALS study record update · 2026-03-05A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia
-
CLINICAL_TRIALS study record update · 2026-03-04A Single-Arm, Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of BCL2 Inhibitor BGB-11417 in Adult Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
-
CLINICAL_TRIALS study record update · 2026-03-04CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
-
CLINICAL_TRIALS study record update · 2026-03-04Spiritual Care to Optimize Relationships and Experience in Adults With Acute Leukemia (SCORE Trial)
-
CLINICAL_TRIALS study record update · 2026-03-03Safety of Targeting PI3Kgamma Signaling With Azacitidine, Venetoclax and Eganelisib in Acute Myeloid Leukemia: A Phase 1 Study (GAVEL)